Daily Archives: December 2, 2021
The Omicron Variant Is a Mystery. Here’s How Science Will Solve It – “So far, panic about the new Covid variant has outpaced actual information. Here’s what scientists around the world are trying to uncover”.
2 Dec, 2021 | 10:08h | UTCThe Omicron Variant Is a Mystery. Here’s How Science Will Solve It – Wired
See also the latest articles on the subject:
Where did ‘weird’ Omicron come from? – Science
We can prevail over Omicron. We just need to use the tools we have – The Guardian
How South African Researchers Identified the Omicron Variant of COVID – The New Yorker
The omicron variant has been found in 23 countries – NPR
These countries have found cases of the Omicron Covid-19 variant so far – CNN
Scientists say it will take weeks to tell how dangerous Omicron really is. Here’s why – CNN
Coronavirus variants: Here’s what we know – CNN
To catch variants like omicron, the world needs to sequence way more virus genes – Vox
Omicron’s Best- and Worst-Case Scenarios – The Atlantic
Africa: tackle HIV and COVID-19 together – Nature
The mystery of where omicron came from — and why it matters – NPR
A reason for optimism on Omicron: Our immune systems are not blank slates – STAT
Omicron – Science-Based Medicine
Covid: Omicron may require ‘very stringent response’, say Sage scientists – BBC
WHO warns against Omicron travel bans as nations shut borders – MedicalXpress
Israeli doctor believes he caught Omicron variant of Covid in London – The Guardian
First case of Omicron coronavirus variant identified in the U.S. – STAT
Retrospective Cohort Study: Except for Rituximab, most immunosuppressive medicines were not associated with increased risk of mechanical ventilation or death in patients hospitalized with Covid-19.
2 Dec, 2021 | 10:07h | UTCCommentaries:
What does endemic COVID-19 mean for the future of rituximab? – The Lancet Rheumatology
Study: Immune-suppressed not at higher risk of poor COVID outcomes – CIDRAP
Commentary on Twitter
NEW RESEARCH—Long-term use of immunosuppressive medicines and in-hospital #COVID19 outcomes: data from N3C shows no increased risk of mechanical ventilation or in-hospital death with the exception of #rituximab https://t.co/vEyTzfvK5q #LancetRheumatology
@JohnsHopkins pic.twitter.com/NqlttjGrpj— The Lancet Rheumatology (@TheLancetRheum) November 16, 2021
AAP Clinical Report | Tuberculosis Infection in Children and Adolescents.
2 Dec, 2021 | 09:58h | UTCTuberculosis Infection in Children and Adolescents: Testing and Treatment – Pediatrics
Systematic Review: Models of COVID-19 vaccine prioritization – “for countries seeking to minimize deaths, prioritizing vaccination of senior adults was the optimal strategy and for countries seeking to minimize cases the young were prioritized”.
2 Dec, 2021 | 10:02h | UTC
World Health Assembly agrees to launch process to develop historic global accord on pandemic prevention, preparedness and response.
2 Dec, 2021 | 10:03h | UTCCommentary: Standing Ovation as WHO Member States Commit to Negotiating New Pandemic Accord – Health Policy Watch
Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence.
2 Dec, 2021 | 10:04h | UTCFluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence – Drugs
Related:
ERS guideline on non-CPAP therapies for obstructive sleep apnea.
2 Dec, 2021 | 09:56h | UTC
AHA Scientific Statement: Supporting physical activity in patients and populations during life events and transitions.
2 Dec, 2021 | 09:53h | UTCNews Release: Major life events influence level of physical activity, may negatively impact heart health – American Heart Association
RCT: Cytoreductive surgery for relapsed ovarian cancer.
2 Dec, 2021 | 09:51h | UTC
The ‘ten commandments’ for the 2021 ESC Guidelines on CVD prevention.
2 Dec, 2021 | 09:45h | UTCThe ‘ten commandments’ for the 2021 ESC Guidelines on CVD prevention – European Heart Journal
Original Article: #ESCCongress – 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Guideline: Management of ureteral calculi.
2 Dec, 2021 | 09:54h | UTCRelated Guidelines:
Chronic cough: new insights and future prospects.
2 Dec, 2021 | 09:43h | UTCChronic cough: new insights and future prospects – European Respiratory Review
RCT: 21-Gene assay to inform chemotherapy benefit in node-positive breast cancer.
2 Dec, 2021 | 09:49h | UTC21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Among postmenopausal women with HR–positive, HER2-negative breast cancer, 1-3 positive lymph nodes, and a 21-gene recurrence score of 25 or lower, 5-year invasive disease–free survival was similar whether they received endocrine or chemoendocrine therapy. https://t.co/aZLXBvSHHl pic.twitter.com/EBVnMkGHx4
— NEJM (@NEJM) December 2, 2021
E-cigarettes may be independently linked to erectile dysfunction.
2 Dec, 2021 | 09:44h | UTCNews Release: E-cigarettes may be independently linked to erectile dysfunction, new research finds – NYU Langone Health
Cohort Study: Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease.
2 Dec, 2021 | 09:47h | UTC
Commentary from the author on Twitter (thread – click for more)
Why did observational studies find ⬆️survival for late dialysis initiation, whereas the IDEAL RCT found no difference? Was it confounding, the usual culprit we point to? No!
Our new paper @bmj_latest addresses this and much more! #epitwitter #nephtwitter https://t.co/rILigIojR1 pic.twitter.com/zDxpQMqnfE
— Edouard L. Fu (@FuEdouard) December 1, 2021